It chose these based on an unmet medical need and a belief that TARIS can meet the need. They both involve a Lidocaine Releasing Intravesical System (LiRIS). The first application ...

TARIS Biomedical has announced the successful completion of a Phase 1 clinical study of its intravesical drug-device convergence system designed to provide sustained-release of drug directly to the ...

The company's lead clinical-stage product, TAR-200, uses the proprietary TARIS System, which features a silicone-based drug delivery device that allows for the continuous release of medication ...

TARIS Biomedical®. "This investment will allow us to advance our lead product candidate, Lidocaine Releasing Intravesical System (LiRIS®), into later stage clinical development for the treatment ...

Taris' bladder delivery platform attracted a ... which fills the bladder for a short period of time. "The system is a small silicone tube that is inserted through a catheter," Senior Vice ...